JYSB1800188 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2018-09-10 | | Wyeth Farma SA;Pfizer Ltd | Certificate Issued | 2019-02-02 | view |
JYSB2200095 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-06-09 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | | | view |
JYSB2300183 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2023-10-26 | | Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG | | | view |
JYSB1800047 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2018-03-26 | | Bayer Healthcare LLC | Certificate Issued | 2018-07-27 | view |
JYSB2101028 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2021-05-12 | | Bayer Healthcare LLC | | | view |
JYSZ2200027 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | License Renew | 2022-06-29 | | Pfizer Europe Ma Eeig;Wyeth Farma SA;Pfizer Investment Co Ltd | | | view |
JYSZ1600012 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | License Renew | 2016-05-10 | | Baxter AG;Baxalta Manufacturing Sàrl | Certificate Issued | 2017-04-19 | view |
JYSB2500202 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2025-09-05 | | Bayer Healthcare LLC | | | view |
JYSB1900244 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2019-09-05 | | Wyeth Farma SA;Pfizer Ltd | Filed | 2019-09-16 | view |
JYSB2200065 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-04-08 | | Novo Nordisk A/S | | | view |
JYSB1500125 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2015-05-08 | | Wyeth Farma SA;Wyeth Pharmaceuticals Inc | Certificate Issued | 2015-08-12 | view |
CXSL2200294 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(2.4) | New Drug Application | 2022-06-28 | | Zhuangya (Beijing) Biotechnology Co Ltd | | | view |
JYSB2400251 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2024-12-04 | | Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG | | | view |
JYSB1000025 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2010-02-09 | | Bayer Healthcare LLC | Certificate Issued | 2010-12-27 | view |
JYSB2000559 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2020-11-04 | | Bayer Healthcare LLC | Filed | 2020-11-17 | view |
JYSB2200144 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-08-08 | | Bayer Healthcare LLC | | | view |
CXSL2400210 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(3.4) | New Drug Application | 2024-04-03 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
JYSB1800114 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2018-05-17 | | Baxter AG;Baxalta Manufacturing Sàrl | Filed | 2018-05-30 | view |
JYSB2000430 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2020-09-03 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | Certificate Issued | 2020-10-27 | view |
JXSS2200007 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(3.1) | Import Drug Application | 2022-01-26 | | Octapharma Ab Sweden;Sichuan Sinco Pharmaceutical Co Ltd | | | view |